Health
Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates – Yahoo Finance
Moderna announces first participants dosed in study evaluating COVID-19 booster vaccine candidates.
Study to enroll 60 participants previously vaccinated with mRNA-1273 in Phase 2, to evaluate booster vaccine candidates against the B.1.351 variant first identified in South Africa
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants have been dosed with the Companys modified COVID-19 vaccines, designed to address the potential need for booster vaccine candidates, in an amendment to the ongoing…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News23 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’
-
General21 hours agoInflation hope as RBA decision leaves many disappointed